Here is a recap of our 10 most read stories in November, featuring Nestle China's new A2 milk launch, new Blackmores CEO on India as a potential new market, Australia’s national regulator proposing to classify non-food appropriate sports supplements as 'medicines', benefits of adding bovine MFGM to infant formula, and Cocoa-Cola China using e-commerce to market BodyArmor exclusively on Tmall.
Here is a recap of our 10 most read stories in November, featuring Nestle China's new A2 milk launch, new Blackmores CEO on India as a potential new market, Australia’s national regulator proposing to classify non-food appropriate sports supplements as 'medicines', benefits of adding bovine MFGM to infant formula, and Cocoa-Cola China using e-commerce to market BodyArmor exclusively on Tmall.
Nestlé China has expanded the target audience for its A2 milk powder products with a new launch catered for the entire family.
New Blackmores CEO Alastair Symington has told us the Australian supplement giant is weighing-up the option of market entry in India, while also preparing to unveil a new multi-channel strategy for China.
Australia’s national regulator, the Therapeutic Goods Administration (TGA), is proposing to classify non-food appropriate sports supplements as therapeutic goods.
Infants who consumed formula containing milk fat globule membrane (MFGM) and lactoferrin (LF) scored higher in cognitive, language and motor tests by their first birthdays, compared to those who consumed formula without the two compounds.
Coca-Cola China is banking on the popularity of digital e-commerce in the country to introduce its second local sports drink BodyArmor to consumers via its Tmall store, along with other products only found in other global markets thus far.
BY-HEALTH and Shanghai Institute for Biological Sciences will jointly set up a research centre that studies nutrition and anti-ageing across the whole of China.
A probiotic strain isolated from cow’s milk in Penang, Malaysia, has been shown to deliver benefits related to brain, respiratory, and gut health.
Research from Morinaga Milk Industry has found that the infant-type human-residential bifidobacteria (HRB) could produce a key metabolite, the immunity-boosting indole-3-lactic acid (ILA), moving one step closer to understanding its benefits on infant health.
Amway plans to invest US$200m in China over the next five years to set up its digital infrastructure, with a global digital innovation centre and a big data centre in the pipeline.
Probiotics supplementation could improve a dysbiotic gut, and in turn manage mood disorders, including major depression.
